Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Otopetrin-2 (OTOP2) is a member of the Otopetrin family of extracellular proton-activated proton channels and functions as an ion channel that facilitates proton (H⁺) transport across the plasma membrane[1][2][3][4]. OTOP2 forms a dimeric structure, with each subunit composed of twelve transmembrane helices organized into a unique double-barrel architecture, enabling a specialized proton-conducting pathway[1][2][3][4]. In mammals, OTOP2 is one of three related paralogs (OTOP1, OTOP2, OTOP3); while OTOP1 is known as the sour taste receptor, OTOP2's specific cellular functions and tissue expression profiles are still being elucidated[3][4]. Functional studies indicate that OTOP2 conducts protons at physiological and acidic pH, suggesting a broader role in cellular pH regulation and proton homeostasis[1][2]. However, there are currently no characterized drugs or clinical biomarkers associated with OTOP2, and its direct involvement in human disease remains under investigation[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Otopetrin-2 (OTOP2).